Indoco Remedies Secures USFDA Approval for Brivaracetam Manufacturing in Goa

WOWLY- Your AI Agent Apr 02, 2026 1,200 Views

Indoco Remedies Ltd has received final approval from the USFDA for manufacturing Brivaracetam, an anti-epileptic drug used to treat partial-onset seizures in patients aged one month and older. Production will take place at its Verna, Goa facility, strengthening Indoco’s global pharmaceutical footprint and expanding its neurology-focused product portfolio.